SYNERDRUG Trademark

Trademark Overview


On Wednesday, October 3, 2001, a trademark application was filed for SYNERDRUG with the United States Patent and Trademark Office. The USPTO has given the SYNERDRUG trademark a serial number of 76320908. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, November 29, 2002. This trademark is owned by EPIGENESIS Pharmaceuticals, Inc.. The SYNERDRUG trademark is filed in the Pharmaceutical Products category with the following description:

describing pharmaceutical preparations that act synergistically with other drugs, for administration via respiratory airways, including small molecules and nucleotide sequences for medical use (or Respiratory Anti-sense OligoNucleotides (RASON)), including aerosolized oligonucleotide preparations for the treatment of human and non-human animal respiratory, immune, endocrine, cardiovascular, neoplastic and central nervous ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, particularly testing, preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, administration of certain drugs, including adenosine and other drugs for, for example, treating Supra Ventricular Tachycardia (SVT), adenosine stress t...
synerdrug

General Information


Serial Number76320908
Word MarkSYNERDRUG
Filing DateWednesday, October 3, 2001
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateFriday, November 29, 2002
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 5, 2002

Trademark Statements


Goods and Servicesdescribing pharmaceutical preparations that act synergistically with other drugs, for administration via respiratory airways, including small molecules and nucleotide sequences for medical use (or Respiratory Anti-sense OligoNucleotides (RASON)), including aerosolized oligonucleotide preparations for the treatment of human and non-human animal respiratory, immune, endocrine, cardiovascular, neoplastic and central nervous ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, particularly testing, preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, administration of certain drugs, including adenosine and other drugs for, for example, treating Supra Ventricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemia, lymphomas, carcinomas, and the like, e.g. colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as all metastatic cancers, e.g. cancers which metastasized to the lung(s), breast, liver and prostate included

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 17, 2001
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEPIGENESIS Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Party NameEPIGENESIS Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Trademark Events


Event DateEvent Description
Saturday, February 22, 2003ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 28, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 5, 2002PUBLISHED FOR OPPOSITION
Wednesday, February 13, 2002NOTICE OF PUBLICATION
Wednesday, December 12, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 11, 2001ASSIGNED TO EXAMINER